<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 270 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page269.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=270">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 270 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 270</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=270"><img src="../thumb/270.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.1.3                                                       2020-04 / 233
                                     Drug interactions: Ser.valproic acid lev.reduc., ren. clear.reduc.  effic.&tolerability.in infts.und.3 mnths not est., verify prev.hypersens.
       18.1.3  Others                by probenecid.               to beta-lactam antibiot., consid. pseudomembr.colit. in pts.develp.di-
                                                                  arrh., do not admin.meds.inhibit.peristals., pre-exist.liv.disords., due
                                     See also MDR page 703.
       DORIBAX (MDR Listing)         INVANZ, MSD [P/S]            to Na content.control.salt diet., safety in pregn. not est., low conc.in
       ADCO-MEROPENEM, (AI Crit.Care) AI Ltd [P/S]  Ertapenem     anim.breast milk, concom. probenecid not recomm.
                                                                  Interactions: Ser.valproic acid lev.reduc., probenecid incr.plas-
       Meropenem trihydrate.         Indications: Mod.to complic.intra-abdom./ complic. skin & skin   ma conc.
       Indications: Sngl./multiple suscept.bact.infects., empiric ther.prior   struct.infects., complic.UT infects.incl.pyelonephrit., community ac-
       to indentificat.of causat.organ.  quir. pneum., ac.pelv.infects.  MERCIDE, Ranbaxy [P/S]
       (S4) POWD.FOR SOL.FOR IV INJ, 44/20.1.1/0206, 0303  (S4) INJ, 37/20.1.1/0424  Meropenem
       721378-001: 500 mg; 1x10 ml vial; R78,14  703413-001: 1 g, sngl.vials, R762,83  Indications: Sngl./multiple suscept.bact.infects., empiric ther.prior
       721380-001: 1 000 mg, 1x20 ml vial, R156,27  Dosage:.Reconstit.& dil.bef.admin.IV infus.over 30 mins./IM.  to indentificat.of causat.organ.
       Dosage: IV admin.as bolus inj.over 5 mins./infus. over 15-30 min.  Usual dos.in pts.over 13 yrs: 1 g once dly. 3 mnths.-12 yrs: 15 mg/  (S4) INJ, 43/20.1.1/0769, 0770.
       Usual dos: Adults: 500 mg-1 g 8 hrly.depend.on type & sev.of infect./  kg 2xdly.not exceed. 1 g/day. Ther durat. 3-14 days depend. on site/   715774-001: 500 mg, 1x10 ml vial, R74,73
       known or expect.suscept.of pathogens & pts.condit.  sev.& clinic.respons.  715775-001: 1 g, 1x20 ml vial, R149,45
       Infts.& childr.over 3 mnths & up to 12 yrs: 10-40 mg/kg 8 hrly.  Contraindications: Bact.meningit., ß-lactam hypersens., amide   Dosage: IV admin.as bolus inj.over 5 mins./infus. over 15-30 min.
       depend.on type & sev.of infect./ known or suspect.susceptibil.of   loc.anaesth.hypersens.& sev. shock/heart block for IM admin.due   Dos depend.on type & sev.of infect. / known or expect.suscept.of
       pathogens & pts condit.       to lidocaine’s use as dil., no data avail.for use in infts.und.3 mnths.,   pathogens & pts. condit.
       Childr.over 50 kg: Adult dos.  safety in pregn.& lactat.not est.  Usual dos: Adults: 500 mg-1 g 8 hrly.
       Febr.episod.in neutropen.pts: Adults: 1 g 8 hrly.  Side effects: Allerg.reacts.incl.anaphylax., seiz., pseudomembr.  Infts.& childr.over 3 mnths & up to 12 yrs: 10-40 mg/kg 8 hrly.
       Meningit: Adults: 2 g 8 hrly. Childr: 40 mg/kg 8 hrly.  colit., super-infect., GI disturbs., loc. reacts., CNS effs., hypotens.,   Childr.over 50 kg: Adult dos.
       Contraindications: Carbapenems/penicill./ other ß-lactam hyper-  dyspn., candidias., erythema, prurit., taste pervers., fatig., oed., fev.,   Febr.episod.in neutropen.pts: Adults: 1 g 8 hrly.
       sens., effic.& tolerabil.in infts.und.3 mnths.not est., safety in pregn.  Meningit: Adults: 2 g 8 hrly. Childr: 40 mg/kg 8 hrly.
       not est., lactat., concom. probenecid not recomm.  pain, chest pain, hallucinat.  Contraindications: Carbapenems/penicill./other ß-lactam antibiot.
                                     Special precautions: Allerg.reacts.more likely in pts. with report.
       Side effects: Inflamm., thrombophlebit., pain, syst. allerg.reacts.incl.  hypersens., safety in pregn.not est., lactat., effic.& tolerabil.in infts.
       angioed & anaphylax., skin reacts. incl.erythema multiforme/Stev.-  multiple allerg.hypersens., penicill. cross-sens., poss. pseudomembr.  und.3 mnths. not est., concom.probenecid not recomm.
                                     colit., ren. insuffic., pre-exist.CNS disords., known fact. predispos. to
       Johns.& tox. epiderm.necrolys., GI disturbs., bld.dyscras., hepatobil.   Side effects: Bld.dyscras., syst.allerg.reacts.incl. angioed & ana-
       disords., headache, paraesthes., convuls., oral & vag.candidias.,   convuls.activ., excret.in breast milk, don’t mix/ infus.with other meds.,   phylax., headache, convuls., paraesthes., GI disturbs., pseudomembr.
       pseudomembr. colit., shock, viscer.vascul.disord., apnoea, pneum.,   don’t use dextr. contain.dilut., reconstit.with 10 ml water for inj./0,9%   colit., hepatobil. disords., skin reacts.incl.erythema multiforme/Stev.-
       hypoglycaem., incr.ser.creatin./bld.urea, prolong./ short. partial   NaCl inj or bacteriostat.water for inj  John.& tox.epiderm.necrolys., inflamm., thrombophlebit., pain, oral
       thromboplast.& prothromb.time, pos.direct/indirect Coombs’test.  Drug interactions: Penicillin/ß-lactam cross-sens., valproic acid   & vag. candidias.
       Warnings and special-precautions: Concom. aminoglycos.   ser.lev.decr.  Special-precautions: Concom.aminoglycos. recomm. in crit.ill pts.
       recomm.in crit.ill pts.with pseudomonas aeruginosa LRTI, do not   LITHA MEROPENEM, Litha [P/S]  with pseudomonas aeruginosa LRTI, imp.ren.funct., do not mix.with/
       mix.with/ add to other sols.contain.other drugs, pre-exist. liv. dis-  Meropenem trihydrate.
       ords., imp.ren.funct., elderly, epilep./brain. les., poss. overgrowth of   Indications: Sngl./multiple suscept.bact.infects., empiric ther.prior   add to other sols.contain.other meds., poss. overgrowth of non-sus-
                                                                  cept.organism, pre-exist.liv. disords
       non-suscept.organism, no exper. with periton.dialys.  to indentificat.of causat.organ.
       Drug interactions: Probenecid incr.plasma conc., ser.valproic   (S4) INJ, 42/20.1.1/0697, 0698  Drug interactions: Probenecid incr.plasma conc., ser.valproic
                                                                  acid lev.reduc.
       acid lev.reduc.               714381-001: 500 mg, 1x10 ml vial, R90,07.
       CILAPEN 500, Ranbaxy [P/S]    714382-001: 1 g, 1x20 ml vial, R181,46.  MEROJECT, Pharma Dynamics [P/S]
       Imipenem 500 mg, cilastatin sod.500 mg.  Dosage: IV admin.as bolus inj.over 5 mins./infus. over 15-30 min.  Meropenem trihydrate.
       Indications: Suscept.intra-abdom., LRT, gynae., septicaem., GUT,   Usual dos: Adults: 500 mg-1 g 8 hrly.depend.on type & sev.of infect./  Indications: Sngl./multiple suscept.bact.infects., empiric ther.prior
       bone & joint, skin & soft tiss. infects., endocardit., aerob.& anaerob.  known or expect.suscept.of pathogens & pts.condit.  to indentificat.of causat.organ.
       G+ve & G-ve infects., mix.infects, sepsis prophylax.aft.colorect. surg.  Infts.& childr.over 3 mnths & up to 12 yrs: 10-40 mg/kg 8 hrly.  (S4) INJ, A42/20.1.1/0280, 0281
       (S4) POWD.FOR INJ. 42/20.1.1/0637.  depend.on type & sev.of infect./ known or suspect.susceptibil.of   718222-001: 500 mg, 1x10 ml, R86,83
       715342-001: 500 mg, 100 ml infus.bot., R208,17  pathogens & pts condit.  718223-001: 1 g, 1x20 ml, R148,93
       Dosage: Treatm: Tot.dly.dos., route of admin.& freq. depend.on   Childr.over 50 kg: Adult dos.  Dosage: IV admin.as infus.over 15-30 min.or by rapid IV inj. of
       type & sev.of infect. Admin.in equal. div. dos.depend.on suscept.  Febr.episod.in neutropen.pts: Adults: 1 g 8 hrly.  3-5 mins.8 hrly.
       of pathog., ren. funct.& bm. Adults &gt;70 kg: 1-2 g dly.in 3-4 div. dos.   Meningit: Adults: 2 g 8 hrly. Childr: 40 mg/kg 8 hrly.  Usual dos: Adults: 500 mg-1 g by IV infus.8 hrly. except.
       Max. 4 g or 50 mg/kg/day. Cystic fibros pts: Up to 90 mg/kg/day in   Contraindications: Carbapenems/penicill./other ß-lactam hy-  Febr.episod.in neutropen.pts: 1 g 8 hrly. Meningit: 2 g 8 hrly.
       div.dos. not exceed.4 g/day. Adults &lt;70 kg /ren.insuffic.appropr.reduc.  persens., effic.& tolerabil.in infts.und.3 mnths. not est., concom.   Childr.over 50 kg: Adult dos. Childr.over 3 mnths & up to 12 yrs:
       dos. regim.as per prod.lit.   probenecid not recomm.       10-40 mg/kg depend.on type & sev.of infect., pts.condit. & known
       Childr.& infts.&lt;40 kg: 15 mg/kg 6 hrly. Max. 2 g/ day. Childr.40 kg   Side effects: Uncommon: Inflamm., thrombophlebit., pain, syst.   or suscept. of pathogen(s) except: Meningit: 40 mg/ kg/dos. 8 hrly.
       & over: Adult dos.            allerg.reacts.incl. angioed. & anaphylax., skin reacts.incl.erythema   Contraindications: Carbapenems/penicill./other ß-lactam hyper-
       Prophylax: Adults: 1 g IV on anaesth.induct. follow. by 1 g 3 hrs.  multiforme/Stev.-Johns.& tox.epiderm.necrolys., GI disturbs., bld.  sens., safety in pregn.not est., lactat., safety & effic.in childr.less
       later. A furth.500 mg admin.8 & 16 hrs.aft.induct.  dyscras., hepatobil.disords., headache, paraesthes., convuls., oral &   than 3 mnths. not est.
       Contraindications: Meningit., safety in pregn.& lactat.not est., chil-  vag. candidias., pseudomembr.colit.  Side effects: Inflamm., thrombophlebit., pain at inj.site, angioed.,
       dr.und.3 mnths./paed.pts.with imp.ren. funct.not recomm.  Warnings and special-precautions: Safety in pregn. not est., lac-  anaphylax., skin reacts.incl. erythema multiforme/Stev.-Johns.& tox.
       Side effects: Bld.dyscras.incl.thrombocytos., decr. Hb, prolong.  tat, concom.aminoglycos. recomm. in crit.ill pts.with pseudomonas   epiderm. necrolys., GI disturbs.incl.diarrh., thrombocytopen., eosino-
       prothromb.time, anaphylact.reacts., CNS effs., psych.disturbs.incl.  aeruginosa LRTI, do not mix.with/add to other sols. contain.other   phil., neutropen.(incl.infreq.agranulocytos.) headache, paraesthes.,
       hallucinat., seiz., hear. loss, GI disturbs., tooth stain., taste pervers.,   drugs, pre-exist.liv.disords., imp.ren. funct., poss.overgrowth of non-  convuls., oral & vag. candidias.
       pseudomembr. colit., hepatit., skin disords.incl. erythem. multiform./  suscept.organism., consid. pseudomembr. colit. in pts.develp.diarrh.  Special-precautions: Concom.aminoglycos. recomm. in crit.
       tox.epiderm.necrolys./exfoliat. dermatit./ Stev.John.syndr., angioed.,   Drug interactions: Probenecid incr.plasma conc., ser.valproic   ill pts.with pseudomonas aeruginosa LRTI with reg.sens.test.,
       candidias., fev., oligur., polyur., anur., ac.ren.fail., red urine, loc. reacts.  acid lev.reduc.  imp.ren. funct., poss.overgrowth of non-suscept.organism., pseu-
       incl.thrombophlebit., alt.liv.funct.test                   domembr. colit.
       Special precautions: Susp.meningit., low sod. diets, granulocy-  MERCARB, Austell [P/S]  Drug interactions: Probenecid incr.plasma conc., ser.valproic
       topen.pts., part.cross-allerg.with other ß-lact. antibiot./penicillin &   Meropenem trihydrate.  acid lev.reduc.
       cephalosporin, combin.with other ß-lactam., prev.ß-lact. hypersens.,   Indications: Sngl./multiple suscept.bact.infects., empiric ther.prior to
       discont.ther.if allerg.reacts.& instit. appropr. treatm., GI dis.hist.esp.  indentificat.of causat.organ. eg. ac.chron.bronchit.& pneumon.exac-  MERONEM, (Pfizer) AstraZeneca [P/S]
       colit., CNS disords., cont.anticonvuls.ther.in known seiz. disord., ren.  erbat., pneumon., UTI in adults & childr., PID, endometrit., skin & skin   Meropenem trihydrate.
       impairm., neurolog.eval./anticonvuls. ther. if seiz./foc.tremor/myo-  struct.infects., meningit.& septicaem.in adults & childr., bact.infects.  Indications: Sngl/multiple suscept.bact.infects., empiric ther.prior
       clon.occur & discont. ther. if CNS sympt.cont., cons.benef./potent.  in host comprom. neutropen. pts., intrabdom.abscess & peritonit.  to indentificat.of causat.organ.
       seiz. risk dur.haemodialys., elderly, may be used in immunocompr.   (S4) POWD.FOR SOL FOR INJ/INFUS, 50/20.1.1/0178, 0179  (S4) INJ, 29/20.1.1/0340, 0341
       pts.for confirm./susp.infects.  3001373-001: 500 mg, 1x20 ml vial, R90,76.  820636-010: 500 mg, 1 vial, R205,60
       Drug interactions: ß-lactamases induc.capable of hydrolyz.other   3001374-001: 1 g, 1x20 ml vial, R155,68.  820644-013: 1 g, 1 vial, R411,20
       ß-lactam antibiot., poss.seiz.with concom.ganciclovir.  Dosage: IV admin.as bolus inj.over 5 mins./infus. over 15-30 min.   Dosage: IV admin.as bolus inj.over 5 mins./infus. over 15-30 min.
                                                                  Usual dos: Adults: 500 mg-1 g 8 hrly. Infts & childr. over 3
       DORIBAX, Takeda [P/S] &       Concom.aminoglycos.recomm.in crit.ill pts.with pseudomonas aer-  mnths:up to 12 yrs: 10-40 mg/kg 8 hrly. Childr.over 50 kg: Adult dos.
                                     uginosa LRTI. Do not mix.with/add to other sols. contain.other meds.
       Doripenem                                                  Febr.episod.in neutropen.pts: Adults: 1 g 8 hrly.
       Indications: Suscept.nosocomial pneumon. excl.ventilat.assoc.  Usual dos: Adults: 500 mg-1 g 8 hrly.depend.on type & sev.of infect./  Meningit: Adults: 2 g 8 hrly. Childr: 40 mg/kg 8 hrly.
       pneumon./complic. intra-abdom.& UTI incl.pyelonephrit.bact.infects.  known or expect.suscept.of pathogens & pts.condit.  Contraindications: Carbapenems/penicill./ other ß-lactam sens.,
       (S4) POWD.FOR SOL.FOR INFUS, 43/20.1.1/0647  Infts.& childr.over 3 mnths & up to 12 yrs: 10-40 mg/kg 8 hrly.  infts.und.3 mnths., concom. probenecid not recomm., safety in
       715810-001: 500 mg, 10x20 ml vials, R5 880,20  depend.on type & sev.of infect./ known or suspect.susceptibil.of   pregn.not est., lactat.
       Dosage: Admin.500 mg 8 hrly.by IV infus.over 1 hr. Nosococomial   pathogens & pts condit.  Side effects: Thrombocythaem., GI disturbs., hepato-bil.disords.,
       pneumonia.x7-14 days. Complicat. intra-abdom.infects x5-14 days.   Childr.over 50 kg: Adult dos.  loc.reacts., bld.dyscras., headache, paraesthes., rash, urticar., pru-
       Complicat. UTI x10 days.      Febr.episod.in neutropen.pts: Adults: 1 g 8 hrly.  rit., convuls., oral & vag.candidias., angioed., anaphylax., pseu-
       Contraindications: Carbapenems/penicill./other ß-lactam hypers-  Meningit: Adults: 2 g 8 hrly. Childr: 40 mg/kg 8 hrly.  domembr.colit., erythema multiforme, Stev.-Johns.& tox.epiderm.
       ens., safety in pregn.& lactat.not est.  Contraindications: Carbapenems/penicill./other ß-lactam hy-  necrolys., super-infect.
       Side effects: Headache, phlebit., N&V, diarrh., prurit., rash, incr.  persens.  Special-precautions: Concom.aminoglycos. recomm. with pseu-
       hepat. enzym., oral candidias., vulvomycot.infects., C.difficile colit.,   Side effects: Freq: Thrombocythaem., headache, N&V, diarrh., ab-  domonas aeruginosa LRTI, clear. by haemodialysis, do not mix.with/
       ser.ac. hypersens.reacts., thrombocytopen.,neutropen., tox. epiderm.  dom.pain, rash, prurit., inflammat., pain. Less freq: Oral & vag.candid-  add to other sols. contain.other drugs, poss. pseudomembr. colit.,
       necrolys., Stev.John.syndr.   ias., eosinophil., thrombocytopen., leucopen., neutropen., agranulocy-  monit.pre-exist.liv.disords. dur. treatm., imp. ren.funct.(creatinine
       Warnings and special-precautions: Incr. mortal.report.in ventilat.-  tos., haemolyt.anaem., angioed., anaphylax., paraesthes., convuls.,   clear. &lt;51 ml/ min)
       assoc.pneumon., anaphylact. reacts.more likely with multiple aller-  antibiot.-assoc. colit., incr.bld.bilirubin, urticar., erythema multiforme,   Drug interactions: Ser. valproic acid lev.reduc., probenecid incr.
       gen sensitiv.hist., pseudomembr.colit.poss., incr.expos.to metabolite   Stev.John.syndr., tox.epiderm. necrolys., incr.bld.creatinine & -urea,   plasma conc.
       in end stage ren.dis. pts., not for inhalat.use as pneumonit.report.  thrombophlebit., inj.site pain.
       with investigat.use, pres.in breast milk of rats, concom. probenecid   Warnings and special-precautions: Enterobacteriaceae/pseu-  MSD-ERTAPENEM, MSD [P/S]
       not recomm., imp.ren.funct., insuffic. info.on dos.with haemodialys.  domon.aeruginosa & Acinetobacter spp.report.resist.to penems,   Ertapenem</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page269.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>&nbsp;&nbsp;&nbsp;<a href="page273.html">273</a>&nbsp;&nbsp;&nbsp;<a href="page274.html">274</a>&nbsp;&nbsp;&nbsp;<a href="page275.html">275</a>
             </td>
             <td width="35%"><a href="page271.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page271.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
